Related Experiment Video
Updated: Jan 6, 2026

14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
16.1K
Single-sample landscape entropy reveals the imminent phase transition during disease progression
Rui Liu1, Pei Chen1, Luonan Chen2,3,4
1School of Mathematics, South China University of Technology, Guangzhou 510640, China.
Bioinformatics (Oxford, England)
|October 11, 2019
Summary
This study introduces the single-sample landscape entropy (SLE) method to predict disease progression from a single omics sample. SLE identifies tipping points and dynamic network biomarkers, enabling early disease detection.
Area of Science:
- Systems Biology
- Computational Biology
- Genomics
Background:
- Biological systems exhibit abrupt state changes during disease progression, marked by tipping points.
- Predicting these disease transitions using omics data is challenging, especially with single-sample availability.
Purpose of the Study:
- To develop a novel method for identifying disease progression tipping points from single omics samples.
- To enable early disease prediction and characterization at an individual level.
Main Methods:
- Introduced the single-sample landscape entropy (SLE) method.
- Evaluated network disorder and criticality using network entropy from single-sample data.
- Identified dynamic network biomarkers associated with disease transitions.
Main Results:
- The SLE method successfully identified tipping points preceding severe disease symptoms in four real-world datasets.
- Validated applications include influenza virus infection, lung cancer metastasis, prostate cancer, and acute lung injury.
- Demonstrated the capability to characterize sample-specific disease states and predict individual disease outcomes.
Conclusions:
- The SLE method provides a robust approach for disease progression analysis using single omics samples.
- This method facilitates early detection and personalized disease state characterization.
- SLE offers a powerful tool for understanding dynamic biological changes during disease onset.

